APA (7th ed.) Citation

Noseda, R., Schain, A. J., Melo-Carrillo, A., Tien, J., Stratton, J., Mai, F., . . . Burstein, R. (2020). Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier. Cephalalgia, 40(3), 229-240. https://doi.org/10.1177/0333102419896760

Chicago Style (17th ed.) Citation

Noseda, Rodrigo, Aaron J. Schain, Agustin Melo-Carrillo, Jason Tien, Jennifer Stratton, Fanny Mai, Andrew M. Strassman, and Rami Burstein. "Fluorescently-labeled Fremanezumab Is Distributed to Sensory and Autonomic Ganglia and the Dura but Not to the Brain of Rats with Uncompromised Blood Brain Barrier." Cephalalgia 40, no. 3 (2020): 229-240. https://doi.org/10.1177/0333102419896760.

MLA (9th ed.) Citation

Noseda, Rodrigo, et al. "Fluorescently-labeled Fremanezumab Is Distributed to Sensory and Autonomic Ganglia and the Dura but Not to the Brain of Rats with Uncompromised Blood Brain Barrier." Cephalalgia, vol. 40, no. 3, 2020, pp. 229-240, https://doi.org/10.1177/0333102419896760.